Expression analysis of thirty one Y chromosome genes in human prostate cancer

Molecular Carcinogenesis

Volumn 27, Issue 4, 2000, Pages 308-321

  Lau, Yun Fai Chris ^a   Zhang, Jianqing ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gene expression; Prostate cancer; Y chromosome

Indexed keywords

ARTICLE; CELL PROLIFERATION; GENE EXPRESSION SYSTEM; GENETIC ANALYSIS; HOUSEKEEPING GENE; HUMAN; HUMAN TISSUE; MALE; MOLECULAR CLONING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; Y CHROMOSOME;

ANDROGENS; BASE SEQUENCE; DNA PRIMERS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; Y CHROMOSOME;

EID: 0034029785     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(200004)27:4<308::AID-MC9>3.0.CO;2-R     Document Type: Article

References (58)

1. Vogt PH, Affara N, Davey P, et al. Report of the Third International Workshop on Y Chromosome Mapping 1997. Heidelberg, Germany, April 13-16, 1997. Cytogenet Cell Genet 1997;79:1-20.
2. Lahn BT, Page DC. Functional coherence of the human Y chromosome. Science 1997;278:675-680.
3. p telomere. Hum Mol Genet 1998;7:407-414.
4. Esposito E, Gianfrancesco F, Ciccodicola A, et al. A novel pseudoautosomal human gene encodes a putative protein similar to Ac-like transposases. Hum Mol Genet 1999;8: 61-67.
5. Goodfellow PN, Lovell-Badge R. SRY and sex determination in mammals. Annu Rev Genet 1993;27:71-92.
6. Cooke HJ, Elliott DJ. RNA-binding proteins and human male infertility. Trends Genet 1997;13:87-89.
7. Shen J, Zhau HE, Hursting SD, Chung LWK. Androgen regulation of the human pseudoautosomal gene MIC2, a potential marker for prostate cancer. Mol Carcinog 1998; 2313-19.
8. Tricoli JV, Bracken RB. ZFY gene expression and retention in human prostate adenocarcinoma. Genes Chrom Cancer 1993;6:65-72.
9. Tricoli JV, Yao JL, D'Souza SA, Bracken RB. Detection of sex-region Y (SRY) transcripts in human prostate adenocarcinoma and benign prostatic hypertrophy. Genes Chrom Cancer 1993;8:28-33.
10. Webber MM, Bello D, Quader S. Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part 1. Cell markers and immortalized nontumorigenic cell lines. Prostate 1996;29: 386-394.
11. Webber MM, Bello D, Quader S. Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications Part 2. Tumorigenic cell lines. Prostate 1997;30:58-64.
12. Don RH, Cox PT, Wainwright BJ, Baker K, Mattick JS. 'Touchdown' PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res 1991;19:4008.
13. Roux KH, Hecker KH. One-step optimization using touchdown and stepdown PCR, Meth Mol Biol 1997;67:39-45.
14. Culig Z, Hobisch A, Hittmair A, et al. Expression, structure, and function of androgen receptor in advanced prostatic carcinoma. Prostate 1998;35:63-70.
15. Young CY, Andrews PE, Tindall DJ. Expression and androgenic regulation of human prostate-specific kallikreins. J Androl 1995;16:97-99.
16. von Lindern M, van Baal S, Wiegant J, Raap A, Hagemeijer A, Grosveld G. Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3′ half to different genes: characterization of the set gene. Mol Cell Biol 1992;12:3346-3355.
17. Belanger A, Hum DW, Beaulieu M, et al. Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues. J Steroid Biochem Mol Biol 1998;65: 301-310.
18. Cleutjens KB, van der Korput HA, Ehren-van Eekelen CC, et al. A 6-kb promoter fragment mimics in transgenic mice the prostate-specific and androgen-regulated expression of the endogenous prostate-specific antigen gene in humans. Mol Endocrinol 1997;11:1256-1265.
19. Cleutjens KB, van der Korput HA, van Eekelen CC, van Rooij HC, Faber PW, Trapman J, An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter. Mol Endocrinol 1997;11:148-161.
20. Schuur ER, Henderson GA, Kmetec LA, Miller JD, Lamparski HG, Henderson DR. Prostate-specific antigen expression is regulated by an upstream enhancer J Biol Chem 1996;271: 7043-7051.
21. Lu S, Tsai SY, Tsai MJ. Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CK1 p16 genes. Cancer Res 1997;57: 4511-4516.
22. Trapman J, Cleutjens KB. Androgen-regulated gene expression in prostate cancer. Semin Cancer Biol 1997;8: 29-36.
23. McElreavey K, Barbaux S, Ion A, Fellous M. The genetic basis of murine and human sex determination: a review. Heredity 1995;75:599-611.
24. Koopman P, Ashworth A, Lovell-Badge R. The ZFY gene family in humans and mice. Trends Genet 1991;7:132-136.
25. Lau YF, Chan KM. The putative testis-determining factor and related genes are expressed as discrete-sized transcripts in adult gonadal and somatic tissues. Am J Hum Genet 1989;45:942-952.
26. Luoh SW, Bain PA, Polakiewicz RD, et al. Zfx mutation results in small animal size and reduced germ cell number in male and female mice. Development 1997;124:2275-2284.
27. Hendriks W, Schepens J, Bachner D, et al. Molecular cloning of a mouse epithelial protein-tyrosine phosphatase with similarities to submembranous proteins. J Cell Biochem 1995;59:418-430.
28. Hunter T. The Croonian lecture. 1997. The phosphorylation of proteins on tyrosine: its role in cell growth and disease. Philos Trans R Soc Lond B Biol Sci 1998;353:583-605.
29. Demoulin JB, Renauld JC. Interleukin 9 and its receptor: an overview of structure and function. Int Rev Immunol 1998;16:345-364.
30. Lau YFC Gonadoblastoma, testicular and prostate cancers and the TSPY gene. Am J Hum Genet 1999;64:921-927.
31. Schnieders F, Dork T, Arnemann J, Vogel T, Werner M, Schmidtke J. Testis-specific protein, Y-encoded (TSPY) expression in testicular tissues. Hum Mol Genet 1996;5: 1801-1807.
32. Zohn IM, Campbell SL, Khosravi-Far R, Rossman KL, Der CJ. Rho family proteins and Ras transformation: the RHOad less traveled gets congested. Oncogene 1998;17:1415-1438.
33. Hotchin NA, Hall A. Regulation of the actin cytoskeleton, integrins and cell growth by the Rho family of small GTPases. In: PJ Parker, T Pawson, editors. Cell signaling Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1996, p 311-322.
34. Khosravi-Far R, Campbell S, Rossman KL, Der CJ. Increasing complexity of Ras signal transduction: involvement of Rho family proteins. Adv Cancer Res 1998;72:57-107
35. de Groot RP, Coffer PJ, Koenderman L. Regulation of proliferation, differentiation and survival by the IL-3/IL-5/ GM-CSF receptor family. Cell Signal 1998;10:619-628.
36. Smith A, Metcalf D, Nicola NA. Cytoplasmic domains of the common beta-chain of the GM-CSF/IL-3/IL-5 receptors that are required for inducing differentiation or clonal suppression in myeloid leukaemic cell lines. Embo J 1997;16: 451-464.
37. Baird PN, D'Andrea RJ, Goodall GJ. Cytokine receptor genes: structure, chromosomal location, and involvement in human disease. Leukemia Lymphoma 1995;18:373-383.
38. Goodall GJ, Bagley CJ, Vadas MA, Lopez AF. A model for the interaction of the GM-CSF, IL-3 and IL-5 receptors with their ligands. Growth Factors 1993;8:87-97.
39. Savarese DM, Valinski H, Quesenberry P, Savarese T. Expression and function of colony-stimulating factors and their receptors in human prostate carcinoma cell lines. Prostate 1998;34:80-91.
40. Rivas CI, Vera JC, Delgado-Lopez F, et al. Expression of granulocyte-macrophage colony-stimulating factor receptors in human prostate cancer. Blood 1998;91:1037-1043.
41. Rokhlin OW, Griebling TL, Karassina NV, Raines MA, Cohen MB. Human prostate carcinoma cell lines secrete GM-CSF and express GM-CSF-receptor on their cell surface. Anticancer Res 1996;16:557-563.
42. Renauld JC, Kermouni A, Vink A, Louahed J, Van Snick J. Interleukin-9 and its receptor: involvement in mast cell differentiation and T cell oncogenesis. J Leuko Biol 1995;57:353-360.
43. Katsuoka Y, Hoshino H, Shiramizu M, Sakabe K, Seiki K. Autoradiographic and cytochemical localization of androgen in human prostatic cancer cell lines. Invest Urol 1986;28:228-231.
44. Garde SV, Sheth AR, Porter AT, Pienta KJ. A comparitive study on expression of prostatin inhibin peptide, prostate acid phosphatase and prostate specific antigen in androgen independent human and rat prostate carcinoma cell lines. Cancer Lett 1993;70:159-166.
45. Bratt O, Kristoffersson U, Lundgren R, Olsson H. The risk of malignant tumours in first-degree relatives of men with early onset prostate cancer: a population-based cohort study. Eur J Cancer 1997;33:2237-2240.
46. Cussenot O, Valeri A, Berthon P, Fournier G, Mangin P. Hereditary prostate cancer and other genetic predispositions to prostate cancer. Urol Int 1998;60(suppl 2):30-34.
47. Glover FE Jr, Coffey DS, Douglas LL, et al. Familial study of prostate cancer in Jamaica. Urol 1998;52:441-443.
48. Ruijter E, van de Kaa C, Miller G, Ruiter D, Deruyne F, Schalken J. Molecular genetics and epidemiology of prostate carcinoma. End Rev 1999;20:22-45.
49. Cooney KA, McCarthy JD, Lange E, et al. Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. J Natl Cancer Irst 1997;89:955-959.
50. Dunsmuir WD, Edwards SM, Lakhani SR, et al. Allelic imbalance in familial and sporadic prostate cancer at the putative human prostate cancer susceptibility locus, HPC1. CRC/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign/British Prostate Group. Br J Cancer 1998;78:1430-1433.
51. Xu J, Meyers D, Freije D, et al. Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet 1998; 20:175-179.
52. Brothman AR. Cytogenetic studies in prostate cancer: are we making progress? Cancer Genet Cytogenet 1997;95: 116-121.
53. Multani AS, Ozen M, Agrawal A, Hopwood VL, von Eschenbach AC, Pathak S. Amplification of the Y chromosome in three murine tumor cell lines transformed in vivo by different human prostate cancers. In Vitro Cell Dev Biol 1999;35:236-239.
54. Geburek BM, Kollmorgen TA, Qian J, D'Souza-Gburek SM, Lieber MM, Jenkins RB. Chromosomal anomalies in stage D1 prostate adenocarcinoma primary tumors and lymph node metastases detected by fluorescence in situ hybridization. J Urol 1997;157:223-227.
55. Konig JJ, Teubel W, van Dongen JW, Romijn JC, Hagemeijer A, Schroder FH. Loss and gain of Chromosomes 1, 18, and Y in prostate cancer. Prostate 1994;25:281-291.
56. Tricoli JV. Y chromosome enumeraton in touch preparations from 42 prostate tumors by interphase fluorescence in situ hybridization analysis. Cancer Genet Cytogenet 1999; 111:1-6.
57. Page DC. Hypothesis: a Y-chromosomal gene causes gonadoblastoma in dysgenetic gonads. Development 1987;101(suppl):151-155.
58. Tsuchiya K, Reijo R, Page DC, Disteche CM. Gonadoblastoma: molecular definition of the susceptibility region on the Y chromosome. Am J Hum Genet 1995;57: 1400-1407.